The values of BASDAI, Visual Analog Scale (VAS) pain, Ankylosing Spondylitis Disease Activity score (ASDAS-CRP), and ASDAS-ESR were significantly lowered after the first 3 months of therapy [6.70 (6.0–8.0) to 3.20 (2.5–3.7), p < 0.001; 72.0 (65.0–78.0) to 23.0 (11.0–35.0), p < 0.001; 4.0 (3.5–4.3) to 1.8 (1.5–2.0), p < 0.001; 3.4 (3.3–3.9) to 1.4 (1.3–2.0), p < 0.001, respectively]. Here, CRP is linked to spondylitis.